HGF/SF-Met signaling in tumor progression

Cell Research

Volumn 15, Issue 1, 2005, Pages 49-51

  Gao, Chong Feng ^a   Vande Woude, George F ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

HGF SF Met; Signaling; Tumor progression

Indexed keywords

CBL PROTEIN; GRB2 PROTEIN, HUMAN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INOSITOL 1,4,5 TRISPHOSPHATE 5 PHOSPHATASE; INOSITOL-1,4,5-TRISPHOSPHATE 5-PHOSPHATASE; ONCOPROTEIN; PHOSPHATASE; RAS PROTEIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL; BIOLOGICAL MODEL; CELL PROLIFERATION; DISEASE COURSE; HUMAN; METABOLISM; METASTASIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL PROLIFERATION; DISEASE PROGRESSION; GRB2 ADAPTOR PROTEIN; HEPATOCYTE GROWTH FACTOR; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PHOSPHORIC MONOESTER HYDROLASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-CBL; PROTO-ONCOGENE PROTEINS C-MET; RAS PROTEINS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 19644395911     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290264     Document Type: Short Survey

References (28)

1. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251:802-4.
2. Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4:915-25.
3. Ponzetto C, Bardelli A, Zhen Z, et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 1994; 77:261-71.
4. Ferracini R, Longati P, Naldini L, et al. Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase. J Biol Chem 1991; 266:19558-64.
5. Maina F, Pante G, Helmbacher F, et al. Coupling Met to specific pathways results in distinct developmental outcomes. Mol Cell 2001; 7:1293-306.
6. Schaeper U, Gehring NH, Fuchs KP, et al. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J Cell Biol 2000; 149:1419-32.
7. Gual P, Giordano S, Williams TA, et al. Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis. Oncogene 2000; 19:1509-18.
8. Maroun CR, Naujokas MA, Holgado-Madruga M, et al. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol 2000; 20:8513-25.
9. Knudsen BS, Feller SM, Hanafusa H. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk. J Biol Chem 1994; 269:32781-7.
10. Knox AL, Brown NH. Rap1 GTPase regulation of adherens junction positioning and cell adhesion. Science 2002; 295:1285-8.
11. Kiyokawa E, Hashimoto Y, Kurata T, et al. Evidence that DOCK180 up-regulates signals from the CrkII-p130(Cas) complex. J Biol Chem 1998; 273:24479-84.
12. Royal I, Park M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells require phosphatidylinositol 3-kinase. J Biol Chem 1995; 270:27780-7.
13. Xiao GH, Jeffers M, Bellacosa A, et al. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci U S A 2001; 98:247-52.
14. Stefan M, Koch A, Mancini A, et al. Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis. J Biol Chem 2001; 276:3017-23.
15. Boccaccio C, Ando M, Tamagnone L, et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 1998; 391:285-8.
16. Zhang YW, Wang LM, Jove R, et al. Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis. Oncogene 2002; 21:217-26.
17. Jeffers M, Taylor GA, Weidner KM, et al. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol Cell Biol 1997; 17:799-808.
18. Petrelli A, Gilestro GF, Lanzardo S, et al. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 2002; 416:187-90.
19. Lee CC, Putnam AJ, Miranti CK, et al. Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis. Oncogene 2004; 23:5193-202.
20. Birchmeier W, Brinkmann V, Niemann C, et al. Role of HGF/SF and c-Met in morphogenesis and metastasis of epithelial cells. Ciba Found Symp 1997; 212:230-40; discussion 240-6.
21. Shinomiya N, Gao CF, Xie Q, et al. RNA interference reveals that ligand-independent Met activity is required for tumor cell signaling and survival. Cancer Res 2004; 64:7962-70.
22. Wang X, DeFrances MC, Dai Y, et al. A mechanism of cell survival: seqestration of Fas by the HGF receptor Met. Mol Cell 2002; 9:411-21.
23. Schmidt L, Duh FM, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997; 16:68-73.
24. Jeffers M, Schmidt L, Nakaigawa N, et al. Activating mutations for the Met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci U S A 1997; 94:11445-50.
25. Graveel C, Su Y, Koeman J, et al. Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutation allele. Proc Natl Acad Sci U S A 2004; 101:17198-203.
26. Lee JH, Han SU, Cho H, et al. A novel germ line juxtamembrane Met in human gastric cancer. Oncogene 2000; 19:4947-53.
27. Ma PC, Kijima T, Maulik G, et al. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Res 2003; 63:6272-81.
28. Peschard P, Fournier TM, Lamorte L, et al. Mutation of the c-Cb1 TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell 2001; 8:995-1004.